Skip to main content
Signal Transduction and Targeted Therapy logoLink to Signal Transduction and Targeted Therapy
. 2020 Jun 19;5:103. doi: 10.1038/s41392-020-00212-9

Correction to: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism

Zhen Zhang 1, Jianjun Li 1, Yang Ou 1, Guang Yang 2, Kaiyuan Deng 1, Qiong Wang 1, Zhaoyang Wang 1, Wenhao Wang 1, Quansheng Zhang 3, Hang Wang 1, Wei Sun 1, Peiqing Sun 4, Shuang Yang 1,
PMCID: PMC7305231  PMID: 34145216

Correction to: Signal Transduction and Targeted Therapy10.1038/s41392-020-0118-x, published online 11 March 2020.

Recently, in the process of collating the raw data, the authors noticed two inadvertent mistakes in Fig. 1 that need to be corrected.1 The correct data are provided as follows. The key findings of the article are not affected by these corrections.

  1. During the preparation of Fig. 1e, the image representing showing vimentin and E-cadherin expression in SUM-159 cells was made a mistake when pasted the picture, which is an inadvertent mistake. After checked the original data, we feel the figure should be as shown here.

    graphic file with name 41392_2020_212_Fig1_HTML.jpg

    Fig. 1e
  2. In the right panel of Fig. 1h, the pillar color of ZEB1/231 cells under Palb treatment was inadvertently made a mistake. After checked the original data, we feel the figure should be as shown here.

    graphic file with name 41392_2020_212_Fig2_HTML.jpg

    Fig. 1h

Reference

  • 1.Zhang Z, Li J, Ou Y, et al. CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism. Sig. Transduct. Target Ther. 2020;5:25. doi: 10.1038/s41392-020-0118-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Signal Transduction and Targeted Therapy are provided here courtesy of Nature Publishing Group

RESOURCES